EPZM

Insider Buys Week of April 2nd 2021

by

For trade details click on this link to the trades Company Ticker GTY Technology Holdings Inc. GTYH You Harry L. Director 10% Owner 61.83% Designer Brands Inc. DBI SCHOTTENSTEIN JAY L Chairman 10% Owner 21.37% Designer Brands Inc. DBI Schottenstein Joseph A. Director 20.34% Green Brick Partners Inc. GRBK Brandler Harry Director 12.61% RHYTHM PHARMACEUTICALS Inc RYTM Meeker David P CEO 10.26% CASI Pharmaceuticals Inc. CASI He Wei-Wu CEO Chairman 9.76% APARTMENT INVESTMENT & MANAGEMENT CO AIV CONSIDINE TERRY Director 9.71% Epizyme Inc. EPZM MOTT DAVID M Director 8.23% REV Group Inc. REVG Rushing Rodney M CEO 6.95% RENT A … Read more

Reality Check- Insider Buying Week Ending 6-26-20

by

It was not a fun week for longs as Coronavirus is on the rise and insiders are blacked out before 2nd quarter earnings. I doubt that insiders were chomping on the bit to buy as the market rebound from the March lows has them unloading their holdings at a record pace. There were a few buys of interest and we highlight them here.  Until we figure out why our embedded Google sheet is not displaying in the RSS feed in our MailChimp blast, here is the link to the trades- Founder and former CEO Eric Lefkofsky bought $5.39 Million worth … Read more

Notable Insider Buying and Selling Week Ending 10-5-18 $ARVN,$$EPZM,$ODT,$IIPR

by

  Earning season is in full swing now so most insiders are blacked out until after their companies report quarterly numbers. Notable buys ARVN Arvinas Inc. Director Ratcliffe bought 1,000,000 shares on the IPO at a price of $16. Dir Flynn and Loven each bought $5 million worth. Arvinas priced at $16 opened at $21. The deal was increased to 7.5 million shares from 6.7 million and priced at the high end of the $14-$16 range but failed to hold support in the rough week the market had. This very early stage biotech company presents an offer to buy below … Read more